June 8, 2008 Los Angeles Times opinion piece by author and Middlebury scholar Sue Halpern says the years of Alzheimer's research may be paying dividends with new treatments that will stave off the disease.
Halpern quotes Cure Alzheimer's Fund Dr. Rudy Tanzi explaining the disease: "The main place where a-beta 42 does its work is in the synapse. So every minute of the day, an Alzheimer patient is producing a-beta 42, for one reason or another, and it's accumulating in the brain ... it's accumulating ... in the synapse. Way, way before the plaques form, you get tiny little aggregates of a-beta 42. The peptides stick together and they get into the synapse and they disrupt the most basic synaptic function for learning and memory."
Click here to view the op-ed
Cure Alzheimer's Fund's Dr. Rudy Tanzi's submitted answers to Senator Hillary Rodham Clinton’s questions from the May 14, 2008, Senate Special Committee on Aging “The Future of Alzheimer’s: Breakthroughs and Challenges”
Washington, May 14, 2008 – Mapping the sequence of the genes susceptible to Alzheimer’s disease provides a novel avenue for potential treatment while also improving the ability to predict risk for Alzheimer’s early in life, Dr. Rudolph Tanzi, chairman of the Cure Alzheimer’s Fund Research Consortium, told the Senate Special Committee on Aging at a hearing today on the disease.
Award winning, national-best selling author David Shenk takes a unique look at Alzheimer’s through a series of four very-short animated films aimed at increasing the understanding of Alzheimer's disease. Cure Alzheimer’s Fund Dr. Rudy Tanzi served in an advisory role to help produce these films. They can be accessed and downloaded at the Web site. The films are free for non-commercial use by anyone at anytime.
Cure Alzheimer’s Fund co-founder Henry McCance has been invited to join the Alzheimer’s Study Group (ASG). The private, non-partisan group will be working hard through this year to form a national strategy to deal effectively with the growing tragedy of Alzheimer’s disease.
Co-chaired by former Speaker of the House and Founder of the Center for Health Transformation Newt Gingrich and former Senator and President of the New School, Bob Kerrey, the ASG is composed of a panel of notables who have committed to develop an Alzheimer’s action plan for the nation by the summer of 2008.
The Alzheimer’s Association, Cure Alzheimer’s Fund, and the Lou Ruvo Brain Institute award the Tomorrow’s Leader in Alzheimer’s Disease Research prize, honoring the legacies of two pioneering Alzheimer researchers – George G. Glenner, M.D., and Leon J. Thal, M.D. The award intends to recognize the work of promising M.D. or Ph.D. Alzheimer’s disease investigators who have made pivotal recent contributions to the goal of eliminating Alzheimer’s.
As part of a yearlong journey and fund-raising campaign that will culminate with an Everest summit attempt in May 2008, Alan Arnette is in Tibet to climb Shisha Pangma. Alan’s mother suffers from Alzheimer’s disease and Alan has incorporated a $100,000 fund-raising campaign as part of his effort to summit the world’s highest mountain. Cure Alzheimer's Fund already has received contributions on Alan’s behalf from many supporters and friends.
In May, Cure Alzheimer’s Fund moved its Massachusetts headquarters to a new location in Wellesley Hills. Our neighbor, CareScout, shares a passion for ending Alzheimer’s disease, and it has been a pleasure to get to know them and their business.
Mountaineer to Raise Awarness, Research Funding for Alzheimer's on Road Back to Everest
Boston - Embarking on a yearlong challenge that he hopes will end at the top of Mt. Everest, mountain climber Alan Arnette will take on a greater challenge along his journey, raising money for research and public awareness of Alzheimer’s disease.
Caleb Finch, Ph.D. joins Scientific Advisory Board
Dr. Finch is a professor of gerontology and biological sciences with adjunct appointments in the Department of Psychology, the Department of Physiology and the Department of Neurology at the University of Southern California. Dr. Finch’s major research interest is the study of genomic controls of mammalian development and aging.
© 2005-2016 Cure Alzheimer's Fund. All rights reserved.